BioSpace News Archive

All aspects of human health, from gene regulation in cells to the efficacy of drugs are governed by the interactions of individual molecules. Advancing human health thus depends critically on our ability to observe and interpret the finest details of these interactions

Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced that its third clinical trial program will be for infantile Krabbe disease, an inherited disease that causes progressive damage to the nervous system.

ITI’s technology platform has the potential to utilize the body’s natural biochemistry to develop a broad immune response and is currently being employed in a Phase II clinical trial as a cancer immunotherapy.

Today eHealth, Inc. (NASDAQ: EHTH) (eHealth.com) released results from a survey of health insurance companies touching on enrollment trends, public policy issues, and the politics of health care in the United States.

IQVIA™ (NYSE:IQV) is pleased to have provided support towards the approval from the U.S. Food and Drug Administration to expand the indications for IBRANCE® (palbociclib) in combination with an aromatase inhibitor or fulvestrant to include the treatment of men with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer

Wetteny Joseph, Senior Vice President & Chief Financial Officer, will present at the Jefferies Healthcare Conference at 3:00 p.m. ET on Thursday, June 6, 2019 in New York, NY.

Submissions can be submitted until Aug. 1

The acquisition of Mana-Tech, Ltd. represents a compelling growth opportunity to expand commercial reach in the UK, Ireland and throughout Europe

Rensselaer Polytechnic Institute (RPI), America’s first technological research university, has found increased efficiencies in multiple critical areas after performing a complete digital transformation utilizing JAGGAER’s advanced Enterprise Reagent Manager (ERM).

Veeva Systems announced participation in the following investor conferences